ECSP045078A - Tiofen- y tiazolsulfonamidas como agentes antineoplásicos - Google Patents
Tiofen- y tiazolsulfonamidas como agentes antineoplásicosInfo
- Publication number
- ECSP045078A ECSP045078A EC2004005078A ECSP045078A ECSP045078A EC SP045078 A ECSP045078 A EC SP045078A EC 2004005078 A EC2004005078 A EC 2004005078A EC SP045078 A ECSP045078 A EC SP045078A EC SP045078 A ECSP045078 A EC SP045078A
- Authority
- EC
- Ecuador
- Prior art keywords
- alkyl
- halo
- alkoxy
- thiazolsulphonamids
- thiophen
- Prior art date
Links
- 229940034982 antineoplastic agent Drugs 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 7
- 125000001475 halogen functional group Chemical group 0.000 abstract 5
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 2
- -1 S-phenyl Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un compuesto de fórmula I: en la que: -X=Y es R1 se selecciona entre el grupo constituido por halo, alquilo C1 - C6, y CF3;R2 se selecciona entre el grupo constituido por halo, -NO2, alquilo C1 - C6, y CF3;R3 es H, alquilo C1 - C6, alcoxi C1 - C4, alquil C1 - C6 tio, o halo;R4 se selecciona entre el grupo constituido por H, halo, alcoxi C1 - C4, alquilo C1 - C6, -COO(alquilo C1 - C6), alquilo C1 - C6 opcionalmente sustituido con alcoxi C1 - C4, ciano, alquil C1 - C6 tio, CF3, S-fenilo, y piridinilo;R5 es halo, alquilo C1 - C6, o alcoxi C1 - C4; ouna sal de adición de base farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35201201P | 2001-10-25 | 2001-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP045078A true ECSP045078A (es) | 2004-06-28 |
Family
ID=23383421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2004005078A ECSP045078A (es) | 2001-10-25 | 2004-04-23 | Tiofen- y tiazolsulfonamidas como agentes antineoplásicos |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7084170B2 (es) |
| EP (1) | EP1442030B1 (es) |
| JP (1) | JP4464681B2 (es) |
| KR (1) | KR100913471B1 (es) |
| CN (1) | CN1298709C (es) |
| AR (1) | AR037248A1 (es) |
| AT (1) | ATE338033T1 (es) |
| AU (1) | AU2002334817B2 (es) |
| BR (1) | BR0212386A (es) |
| CA (1) | CA2463300C (es) |
| CY (1) | CY1106247T1 (es) |
| DE (1) | DE60214413T2 (es) |
| DK (1) | DK1442030T3 (es) |
| EA (1) | EA006081B1 (es) |
| EC (1) | ECSP045078A (es) |
| EG (1) | EG26021A (es) |
| ES (1) | ES2269816T3 (es) |
| HR (1) | HRP20040371B1 (es) |
| HU (1) | HUP0401638A3 (es) |
| IL (2) | IL160851A0 (es) |
| MX (1) | MXPA04003886A (es) |
| MY (1) | MY130718A (es) |
| NO (1) | NO20041316L (es) |
| NZ (1) | NZ531136A (es) |
| PE (1) | PE20030574A1 (es) |
| PL (1) | PL208083B1 (es) |
| PT (1) | PT1442030E (es) |
| SI (1) | SI1442030T1 (es) |
| SV (1) | SV2004001367A (es) |
| TW (1) | TWI281916B (es) |
| UA (1) | UA75716C2 (es) |
| WO (1) | WO2003035629A1 (es) |
| ZA (1) | ZA200403089B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6881741B2 (en) * | 2001-06-11 | 2005-04-19 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
| SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| US7375131B2 (en) * | 2002-06-06 | 2008-05-20 | Smithklinebeecham Corp. | NF-κB inhibitors |
| KR101058696B1 (ko) * | 2002-12-10 | 2011-08-22 | 바이로켐 파마 인코포레이티드 | 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법 |
| SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| JP5134247B2 (ja) * | 2004-09-13 | 2013-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有化合物の血管新生阻害物質との併用 |
| WO2006030947A1 (ja) * | 2004-09-13 | 2006-03-23 | Eisai R & D Management Co., Ltd. | スルホンアミド含有化合物の血管新生阻害物質との併用 |
| US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
| CA2599301A1 (en) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| WO2006090932A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Managemant Co., Ltd. | スルホンアミド化合物の代理マーカー |
| SI1859793T1 (sl) | 2005-02-28 | 2011-08-31 | Eisai R&D Man Co Ltd | Nova kombinirana uporaba sulfonamidne spojine za zdravljenje raka |
| WO2006119646A1 (en) * | 2005-05-13 | 2006-11-16 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| US7208506B2 (en) * | 2005-07-07 | 2007-04-24 | Hoffmann-La Roche Inc. | Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| US7625896B2 (en) * | 2005-11-25 | 2009-12-01 | Hoffman-La Roche Inc. | Pyridylsulfonamide derivatives |
| US20100291592A1 (en) | 2006-04-20 | 2010-11-18 | Taro Semba | Novel marker for sensitivity against sulfonamide compound |
| US7939532B2 (en) | 2006-10-26 | 2011-05-10 | Hoffmann-La Roche Inc. | Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| JP5290186B2 (ja) * | 2006-11-15 | 2013-09-18 | ヴァイロケム ファーマ インコーポレイテッド | フラビウイルス感染症の治療または予防用のチオフェン類似体 |
| JP2010526844A (ja) | 2007-05-16 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | アリールピリジルスルホンアミド誘導体、それらの製造法及び医薬剤としての使用 |
| CN101899008B (zh) * | 2010-05-20 | 2012-10-17 | 中国人民解放军第二军医大学 | N-取代嘧啶磺酰基-取代苯甲酰胺类化合物及其制备药物的用途 |
| CN103450149B (zh) * | 2012-06-01 | 2015-10-14 | 中国科学院上海有机化学研究所 | 苯基噻吩磺酰胺类化合物及其制备方法和用途 |
| JP6364967B2 (ja) * | 2014-05-30 | 2018-08-01 | 東ソー株式会社 | ジチエノベンゾジチオフェンの製造方法 |
| CN106588868A (zh) * | 2016-11-16 | 2017-04-26 | 武汉理工大学 | 一种2‑溴‑3‑噻吩甲酸中间体的合成方法 |
| CN108558822B (zh) * | 2018-06-01 | 2020-12-18 | 盐城锦明药业有限公司 | N-((5-溴噻吩-2-基)磺酰基)-2,4-二氯苯甲酰胺的合成方法 |
| CN110835345A (zh) * | 2018-08-17 | 2020-02-25 | 中国科学院上海药物研究所 | 一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途 |
| CN109265437A (zh) * | 2018-10-19 | 2019-01-25 | 凯莱英医药集团（天津）股份有限公司 | 一种3-羟基噻吩-2-羧酸酯类化合物的制备方法 |
| WO2024251876A1 (en) * | 2023-06-07 | 2024-12-12 | KRæFTENS BEKæMPELSE | PROTACs AND HyT-PD MOLECULES FOR TARGETED PROTEIN DEGRADATION OF DCAF15 AND THEIR USE IN THE TREATMENT OF AMYLOIDOSIS |
| WO2025031360A1 (zh) * | 2023-08-09 | 2025-02-13 | 上海科技大学 | 磺酰胺类化合物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA813332B (en) * | 1980-06-21 | 1982-05-26 | Pfizer | Larvicides and isecticides |
| NZ238911A (en) * | 1990-07-17 | 1993-10-26 | Lilly Co Eli | Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor |
| US5177074A (en) * | 1991-03-26 | 1993-01-05 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5169860A (en) * | 1992-03-13 | 1992-12-08 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| AU737038B2 (en) * | 1996-07-05 | 2001-08-09 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof |
| EP0929540A4 (en) | 1996-10-04 | 2001-12-12 | Lilly Co Eli | ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS |
| JP4316787B2 (ja) | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
-
2002
- 2002-10-11 TW TW091123452A patent/TWI281916B/zh not_active IP Right Cessation
- 2002-10-15 CA CA2463300A patent/CA2463300C/en not_active Expired - Fee Related
- 2002-10-15 SI SI200230399T patent/SI1442030T1/sl unknown
- 2002-10-15 IL IL16085102A patent/IL160851A0/xx unknown
- 2002-10-15 PL PL368234A patent/PL208083B1/pl not_active IP Right Cessation
- 2002-10-15 NZ NZ531136A patent/NZ531136A/en not_active IP Right Cessation
- 2002-10-15 US US10/490,935 patent/US7084170B2/en not_active Expired - Fee Related
- 2002-10-15 CN CNB028212150A patent/CN1298709C/zh not_active Expired - Fee Related
- 2002-10-15 DE DE60214413T patent/DE60214413T2/de not_active Expired - Lifetime
- 2002-10-15 AU AU2002334817A patent/AU2002334817B2/en not_active Ceased
- 2002-10-15 ES ES02802117T patent/ES2269816T3/es not_active Expired - Lifetime
- 2002-10-15 KR KR1020047006058A patent/KR100913471B1/ko not_active Expired - Fee Related
- 2002-10-15 HR HRP20040371AA patent/HRP20040371B1/xx not_active IP Right Cessation
- 2002-10-15 UA UA20040403046A patent/UA75716C2/uk unknown
- 2002-10-15 PT PT02802117T patent/PT1442030E/pt unknown
- 2002-10-15 EA EA200400582A patent/EA006081B1/ru not_active IP Right Cessation
- 2002-10-15 JP JP2003538145A patent/JP4464681B2/ja not_active Expired - Fee Related
- 2002-10-15 WO PCT/US2002/031568 patent/WO2003035629A1/en not_active Ceased
- 2002-10-15 MX MXPA04003886A patent/MXPA04003886A/es active IP Right Grant
- 2002-10-15 EP EP02802117A patent/EP1442030B1/en not_active Expired - Lifetime
- 2002-10-15 DK DK02802117T patent/DK1442030T3/da active
- 2002-10-15 HU HU0401638A patent/HUP0401638A3/hu unknown
- 2002-10-15 BR BR0212386-0A patent/BR0212386A/pt not_active IP Right Cessation
- 2002-10-15 AT AT02802117T patent/ATE338033T1/de active
- 2002-10-21 EG EG2002101152A patent/EG26021A/en active
- 2002-10-23 AR ARP020104007A patent/AR037248A1/es active IP Right Grant
- 2002-10-23 MY MYPI20023959A patent/MY130718A/en unknown
- 2002-10-24 SV SV2002001367A patent/SV2004001367A/es unknown
- 2002-10-25 PE PE2002001051A patent/PE20030574A1/es not_active Application Discontinuation
-
2004
- 2004-03-11 IL IL160851A patent/IL160851A/en not_active IP Right Cessation
- 2004-03-30 NO NO20041316A patent/NO20041316L/no not_active Application Discontinuation
- 2004-04-22 ZA ZA200403089A patent/ZA200403089B/en unknown
- 2004-04-23 EC EC2004005078A patent/ECSP045078A/es unknown
-
2006
- 2006-06-06 US US11/447,457 patent/US7250430B2/en not_active Expired - Fee Related
- 2006-11-16 CY CY20061101669T patent/CY1106247T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP045078A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplásicos | |
| BRPI0511504A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides | |
| HRP20090195T1 (hr) | Inhibitori mitotičkih kinezina | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| CO5261589A1 (es) | Compuestos heterociclicos, su produccion y su utilizacion | |
| GB9801690D0 (en) | Therapeutic agents | |
| ES2175901T3 (es) | Benzoimidazoles como inhibidores de la cilooxigenasa-2. | |
| ES2192520T3 (es) | Composicion farmaceutica. | |
| ATE302775T1 (de) | Carbolinderivate | |
| AR060159A2 (es) | Combinaciones de compuestos derivados de tropano utiles en terapia | |
| TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| BR0206943A (pt) | Inibidores de fosfodiesterase 4 | |
| AR037940A1 (es) | Compuestos antivirales de piridoquinoxalina | |
| IL190024A0 (en) | Stabilized protease composition | |
| DE60220296D1 (de) | IMIDAZO(1,2-a)PYRIMIDINE UND DIESE ENTHALTENDE FUNGIZIDZUSAMMENSETZUNGEN | |
| CL2004000519A1 (es) | Composicion herbicida que comprende 3-(3-sulfamoil carboxamida fenil) uracilos y por lo menos otro herbicida seleccionado entre 6 posibilidades y opcionalmente un protector; agente herbicida que comprende la composicion; metodo para controlar la vege | |
| AU9025601A (en) | Cephem compounds and esbl-detecting reagents containing the same | |
| BR0101551A (pt) | Composição para controle de artrópodes | |
| WO2004099130A3 (en) | 1,2-diarylimidazoles useful as inhibitors of cox | |
| AR027035A1 (es) | Pirroles sustituidos | |
| EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие | |
| HRP20030653B1 (en) | Novel benzoylguanidine salt | |
| ES2183500T3 (es) | Nuevos compuestos y composiciones farmaceuticas que los contienen. | |
| MXPA03008725A (es) | Medicamentos para hiperactividad vesicular. | |
| EA200400667A3 (ru) | Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат |